Navigation Links
GTT Group’s Patent Equity Fund, Ideaship, Invests in Captis Biotechnology, Inc. to Develop Reliable and Inexpensive Diagnostic Platforms for Early Disease Detection
Date:4/22/2020

Captis Biotechnology, Inc. announced it has received an investment from Ideaship, a patent leveraged venture capital firm that provides patent development support for early stage startups. The investment will support Captis’ mission to develop diagnostic platforms to detect and treat illnesses such as ovarian cancer and precancerous pancreatic lesions with simple, accurate and practical technology.

“We are grateful to be working with Dr. Strongin and the Captis Team. Their innovations promise to provide a new pathway for understanding and eventual treatment of diseases that have all too often been diagnosed much later than desirable for positive patient outcomes,” remarked Michael Lubitz, Co-founder of Ideaship and Managing Director and Founder of GTT Group.

“Ideaship will add value to our company for our investors and will aid our success in navigating IP issues as well as other major business issues and strategies,” noted Robert Strongin, Co-founder, President, and CEO of Captis.

About Captis

Captis Biotechnology, Inc. is based in Portland, Oregon. Captis is a diagnostic company whose goal is to address major challenges in early disease detection. The research conducted by Captis will assist in the treatment of chronic diseases such as cancer, cardiovascular and alzheimer’s.

For more information, please visit https://www.captisbiotech.com/.

About Ideaship

Ideaship provides patent development capital for early stage ventures.

Ideaship is a collaboration between Global Technology Transfer Group (GTT Group) and Panasonic Intellectual Property Corporation of America. Ideaship combines the expertise and experience of GTT Group’s patent analysis, valuation, and monetization practices with Panasonic Intellectual Property Corporation of America’s leading patent department to achieve enterprise value premiums.

For more information, please visit https://www.ideashipfund.com/.

Contact about this news:

Ideaship
Robert Bell
Email: robert@ideashipfund.com

Captis Biotechnology, Inc.
Robert Strongin
Email: strongin@captisbiotech.com

Read the full story at https://www.prweb.com/releases/gtt_groups_patent_equity_fund_ideaship_invests_in_captis_biotechnology_inc_to_develop_reliable_and_inexpensive_diagnostic_platforms_for_early_disease_detection/prweb17025172.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related biology news :

1. Crystal Diagnostics Granted New Patent for Rapid Detection of Foodborne Pathogens
2. Atlantic Ultraviolet Corporation’s Patented Automatic and Manual Wipers Voted #1 Best Feature of the SANITRON® and MEGATRON® Water Purifiers by Distributors
3. Australian Patent Office Grants Patent Covering RoosterBio’s Novel Compositions and Formulations for Ready-to-Print (RTP) Cells
4. Panitch Schwarze Belisario & Nadel LLP Welcomes Gunes Bender as Patent Agent
5. Noblis Receives U.S. Patent for SNP Analysis and Genome Sequencing System and Methods
6. uBiome Awarded Eighth Patent for the Characterization of Skin Related Conditions
7. Peer-Reviewed Paper in Frontiers in Bioengineering and Biotechnology Reveals that uBiome Has the Largest Patent Portfolio in the Microbiome Space
8. StressMarq Biosciences Inc. PCT Patent Application for a Novel Antibody Therapeutic Candidate to Combat Parkinson’s Disease is Published
9. rHEALTH Technology Receives Notice of Allowance from US Patent Office for Multiplexed Tests in Small Sample Volumes
10. uBiome Receives Patent for Microbiome-Derived Diagnostics and Therapeutics for Immune-Microbial Dysfunction
11. EyeLock Receives Patent for Sequentially Linking Iris Matching With Facial Imaging
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2020)... ... July 01, 2020 , ... Cure Glioblastoma, a registered 501(c)(3) ... and aggressive adult brain cancer—announced today the appointments of its first Senior Fellows: ... supporting the organization’s initiatives and overall vision. , "Senior Fellows are more than ...
(Date:6/28/2020)... ... June 25, 2020 , ... In an upcoming episode scheduled for the ... of Care Testing solutions (POCT). Check local listings for more info. , Today, the ... and are shipped to labs throughout the country. Results are then available several days ...
(Date:6/23/2020)... (PRWEB) , ... June 23, ... ... provider of gene-to-protein and monoclonal antibody development services, today announced that the ... products and services to the pharmaceutical, diagnostics, and research industries. The decision ...
Breaking Biology News(10 mins):
(Date:7/10/2020)... ... July 08, 2020 , ... ... products, announces a significant expansion of laboratory operations through its COVID-19 testing ... implementing testing programs. , Bode-CARES provides a turnkey solution that ...
(Date:7/10/2020)... LEXINGTON, Mass. (PRWEB) , ... July 09, 2020 ... ... novel approaches to cell therapy, today announced the hiring of Allen R. Nissenson, ... executive team and oversee the clinical development of Sentien’s lead product, SBI-101. ...
(Date:7/1/2020)... ... 29, 2020 , ... MedShift , a leading medical ... many obstacles created as a result of COVID-19. As a provider at the ... practices and medical manufacturers by expanding access to device offerings, technology services, and ...
(Date:6/28/2020)... (PRWEB) , ... June 25, 2020 , ... The Indoor ... launch of Safe Space™ for businesses of all types to ensure cleanliness, distancing and ... , A Safe Space™ enabled business will provide a health performance index ...
Breaking Biology Technology: